US Stock MarketDetailed Quotes

BFRI Biofrontera

Watchlist

1.1200
+0.0300+2.75%

Close Jan 3 16:00 ET

1.1200
0.00000.00%

Pre 06:13 ET

8.68MMarket Cap0.97P/E (TTM)

Biofrontera Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biofrontera Q3 2024 Earnings Date

Currency：USDNov 13, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	10.01M	9.01M	-994.50K
Miss Est.	+12.48%	+1.30%	-9.94%
EPS	-0.83	-0.98	-0.15
Miss Est.	+82.01%	+78.88%	-17.38%

Analyst Rating

Buy

Jan 5, 2025

Biofrontera Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 11.500M	--
--	2024/Q4	-- / 14.531M	--
Nov 13, 2024	2024/Q3	9.012M / 10.007M	--
Aug 14, 2024	2024/Q2	7.839M / 8.207M	--
May 15, 2024	2024/Q1	7.912M / 10.857M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 11.500M--

--2024/Q4-- / 14.531M--

Nov 13, 20242024/Q39.012M / 10.007M--

Aug 14, 20242024/Q27.839M / 8.207M--

May 15, 20242024/Q17.912M / 10.857M--

Unlock Free Earnings Estimates

Open Account

Biofrontera Earnings Reports

10-Q: Q3 2024 Earnings Report

Nov 14, 2024 11:34 ET

8-K: Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Nov 13, 2024 17:23 ET

10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:21 ET

8-K: Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

May 15, 2024 17:26 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 5, 2025

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data